These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7300267)

  • 1. Ataxic dysarthria: treatment sequences based on intelligibility and prosodic considerations.
    Yorkston KM; Beukelman DR
    J Speech Hear Disord; 1981 Nov; 46(4):398-404. PubMed ID: 7300267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of rate control on the intelligibility and naturalness of dysarthric speech.
    Yorkston KM; Hammen VL; Beukelman DR; Traynor CD
    J Speech Hear Disord; 1990 Aug; 55(3):550-60. PubMed ID: 2381196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing speech supplementation strategies: effects on intelligibility and speech rate of individuals with chronic severe dysarthria.
    Hustad KC; Jones T; Dailey S
    J Speech Lang Hear Res; 2003 Apr; 46(2):462-74. PubMed ID: 14700386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of strategies to increase speech intelligibility in cerebral palsy: an experimental evaluation.
    Hunter L; Pring T; Martin S
    Br J Disord Commun; 1991 Aug; 26(2):163-74. PubMed ID: 1777397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Speech rate treatments for individuals with dysarthria: a tutorial.
    Blanchet PG; Snyder GJ
    Percept Mot Skills; 2010 Jun; 110(3 Pt 1):965-82. PubMed ID: 20681347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Intelligibility Gains in Individuals With Dysarthria From Baseline Speech Features.
    Fletcher AR; McAuliffe MJ; Lansford KL; Sinex DG; Liss JM
    J Speech Lang Hear Res; 2017 Nov; 60(11):3043-3057. PubMed ID: 29075753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of speech rate and loudness on speech intelligibility].
    Barreto Sdos S; Ortiz KZ
    Pro Fono; 2008; 20(2):87-92. PubMed ID: 18622515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shorter Sentence Length Maximizes Intelligibility and Speech Motor Performance in Persons With Dysarthria Due to Amyotrophic Lateral Sclerosis.
    Allison KM; Yunusova Y; Green JR
    Am J Speech Lang Pathol; 2019 Feb; 28(1):96-107. PubMed ID: 31072158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auditory vs visual speech timing cues as external rate control to enhance verbal intelligibility in mixed spastic-ataxic dysarthric speakers: a pilot study.
    Pilon MA; McIntosh KW; Thaut MH
    Brain Inj; 1998 Sep; 12(9):793-803. PubMed ID: 9755370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparing an E-learning-based Speech Therapy (EST) efficacy study: Identifying suitable outcome measures to detect within-subject changes of speech intelligibility in dysarthric speakers.
    Beijer LJ; Rietveld AC; Ruiter MB; Geurts AC
    Clin Linguist Phon; 2014 Dec; 28(12):927-50. PubMed ID: 25025268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Intelligibility Gains in Dysarthria Through Automated Speech Feature Analysis.
    Fletcher AR; Wisler AA; McAuliffe MJ; Lansford KL; Liss JM
    J Speech Lang Hear Res; 2017 Nov; 60(11):3058-3068. PubMed ID: 29075755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of rate control on speech rate and intelligibility of dysarthric speech.
    Van Nuffelen G; De Bodt M; Wuyts F; Van de Heyning P
    Folia Phoniatr Logop; 2009; 61(2):69-75. PubMed ID: 19287175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Communication efficiency of dysarthric speakers as measured by sentence intelligibility and speaking rate.
    Yorkston KM; Beukelman DR
    J Speech Hear Disord; 1981 Aug; 46(3):296-301. PubMed ID: 7278175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of severe dysarthria: a case study.
    Simpson MB; Till JA; Goff AM
    J Speech Hear Disord; 1988 Nov; 53(4):433-40. PubMed ID: 2972886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acoustic changes in the speech of children with cerebral palsy following an intensive program of dysarthria therapy.
    Pennington L; Lombardo E; Steen N; Miller N
    Int J Lang Commun Disord; 2018 Jan; 53(1):182-195. PubMed ID: 28714530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serious game for speech training in dysarthric speakers with Parkinson's disease: Exploring therapeutic efficacy and patient satisfaction.
    Ganzeboom M; Bakker M; Beijer L; Strik H; Rietveld T
    Int J Lang Commun Disord; 2022 Jul; 57(4):808-821. PubMed ID: 35338751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of speech cues in French-speaking children with dysarthria.
    Levy ES; Moya-Galé G; Chang YM; Campanelli L; MacLeod AAN; Escorial S; Maillart C
    Int J Lang Commun Disord; 2020 May; 55(3):401-416. PubMed ID: 32077196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAF as instrumental treatment for dysarthria in progressive supranuclear palsy: a case report.
    Hanson WR; Metter EJ
    J Speech Hear Disord; 1980 May; 45(2):268-76. PubMed ID: 6449631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.